Bio-link Australia Pty. Ltd.


Please find below a list of selected recent news and press releases from Bio-Link, our clients and the industry. Please select a specific news list for each source from the buttons on the left hand side.

15th March 2011 – Deal Announcement

Bio-Link has facilitated a global licence, supply and distribution agreement for a range of small molecule dynamin inhibitors for research purposes, between the Children’s Medical Research Institute and University of Newcastle, and Ascent Scientific (United Kingdom) a multinational provider of high quality receptor ligands and synthetic chemistry services. Click here for the full press release…

17th February 2010 – Bio-Link Engaged by QRxPharma

Bio-Link has been engaged by QRxPharma to assist in partnering the TorsinA Drug Discovery Program for Protein Misfolding Diseases. Lead indications are Parkinson’s disease and early-onset torsion dystonia. QRxPharma is the exclusive licensee of the Program, which is located at the University of Alabama.